Related Experiment Video
Updated: Mar 26, 2026

Robot-assisted Partial Splenectomy
Published on: January 2, 2026
Long-term outcomes after pediatric splenectomy
Topi T Luoto1, Mikko P Pakarinen1, Antti Koivusalo1
1Section of Pediatric Surgery, Pediatric Liver and Gut Research Group, Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Insights
Long-term outcomes after pediatric splenectomy show that postsplenectomy sepsis is rare and linked to immunodeficiency. Portal vein thrombosis (PVT) was not observed, but retained accessory spleen occurred in 7% of cases.
Area of Science:
- Pediatric Surgery
- Hematology
- Immunology
Background:
- Splenectomy is a common procedure in children and adolescents, primarily for hematologic conditions.
- Long-term complications such as sepsis, portal vein thrombosis (PVT), and retained accessory spleen require thorough investigation.
Purpose of the Study:
- To analyze the long-term outcomes of splenectomy in pediatric patients.
- To assess the incidence of sepsis, PVT, and retained accessory spleen after splenectomy.
Main Methods:
- A cohort of 141 children undergoing open or laparoscopic splenectomy between 1991 and 2010 was followed.
- Nationwide registries were used to track septic infections, PVT, and mortality.
- Patients underwent questionnaires and ultrasonography for follow-up assessments.
Main Results:
- Postsplenectomy sepsis occurred in 8% of patients, predominantly those with underlying immunodeficiency, and was associated with high mortality.
- No cases of portal vein thrombosis (PVT) were observed.
- A retained accessory spleen was identified in 7% of patients, with a slightly higher incidence after laparoscopic procedures.
Conclusions:
- Postsplenectomy sepsis in children is strongly associated with immunodeficiency and carries a significant mortality risk.
- The risk of portal vein thrombosis (PVT) after splenectomy appears low in this pediatric cohort.
- Retained accessory spleen is a notable complication, occurring more frequently after laparoscopic splenectomy.
Background:
Splenectomy is performed frequently for various and primarily hematologic indications in children and adolescents. We analyzed the long-term outcome after splenectomy (median, 8.7 years) focusing on sepsis, portal vein thrombosis (PVT), and retained accessory spleen.
Methods:
In total, 141 consecutive children after open (n = 89; 63%) or laparoscopic (n = 52; 37%) splenectomy from 1991 to 2010 were followed up through nationwide registries for septic infections, PVT, and causes of death. Sixty-six patients (58% of survivors) answered a structured questionnaire on infections, abdominal symptoms, and general health, and 64 (laparoscopic n = 26, open n = 38) consented to ultrasonography of the portal venous system.
Results:
Median operation age was 8.8 years (range, 1.0-22). Reoperations were required for bleeding after open procedures (n = 1) and retained accessory spleen after laparoscopic procedures (n = 3). Postsplenectomy sepsis occurred after a median of 1.7 years (range, 0.2-5.9) in 11 patients (8%), of whom 10 had an underlying immunodeficiency. No cases of PVT were observed, although the median portal vein flow was 1,130 mL/min (range, 440-2200) and diameter was 9.9 mm (range, 7-15) at a median follow-up of 9.5 years (range, 2.0-22) after splenectomy. Twenty-seven patients (19%) died after 8.7 years (0.03-23.00). The most common cause of death was the underlying malignancy (n = 15), with sepsis being an additional cause of death in 5 patients.
Conclusion:
Postsplenectomy sepsis was associated almost exclusively with an underlying immunodeficiency with a high mortality rate. No PVT was observed. The overall risk of retained accessory spleen was around 7%, and was slightly greater after laparoscopic operation.
More Related Videos
02:09Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
Published on: December 20, 2024
08:04A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
Published on: June 11, 2019
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant I: Introduction